CCL2 plays an active role in the recruitment of monocytes, NK cells, and other inflammatory cells, and hence is a significant contributor to the inflammatory cascade, which is a turning point in IR and MS [43,44]. This evidence concerns the gene CCL2 and myeloid sarcoma.